Modalis Therapeutics Corp
TSE:4883
Income Statement
Earnings Waterfall
Modalis Therapeutics Corp
Revenue
|
0
JPY
|
Operating Expenses
|
-2.4B
JPY
|
Operating Income
|
-2.4B
JPY
|
Other Expenses
|
-21.2m
JPY
|
Net Income
|
-2.4B
JPY
|
Income Statement
Modalis Therapeutics Corp
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
342
N/A
|
330
-4%
|
6
-98%
|
3
-49%
|
1
-65%
|
41
+3 627%
|
41
-1%
|
41
N/A
|
41
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(740)
|
(864)
|
(921)
|
(911)
|
(1 241)
|
(1 497)
|
(1 673)
|
(2 043)
|
(2 104)
|
(2 111)
|
(2 240)
|
(2 234)
|
(2 371)
|
|
Selling, General & Administrative |
(208)
|
(230)
|
(244)
|
(234)
|
(231)
|
(227)
|
(232)
|
(234)
|
(242)
|
(248)
|
(250)
|
(262)
|
(268)
|
|
Research & Development |
(532)
|
(452)
|
(494)
|
(494)
|
(1 010)
|
(1 268)
|
(1 439)
|
(1 807)
|
(1 862)
|
(1 863)
|
(1 989)
|
(1 973)
|
(2 103)
|
|
Other Operating Expenses |
(0)
|
(183)
|
(183)
|
(183)
|
(0)
|
(2)
|
(2)
|
(2)
|
0
|
(0)
|
0
|
0
|
(0)
|
|
Operating Income |
(398)
N/A
|
(535)
-34%
|
(914)
-71%
|
(908)
+1%
|
(1 239)
-37%
|
(1 456)
-17%
|
(1 633)
-12%
|
(2 002)
-23%
|
(2 063)
-3%
|
(2 111)
-2%
|
(2 240)
-6%
|
(2 234)
+0%
|
(2 371)
-6%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(5)
|
2
|
12
|
16
|
11
|
28
|
87
|
120
|
72
|
54
|
36
|
19
|
35
|
|
Non-Reccuring Items |
0
|
486
|
486
|
486
|
484
|
0
|
0
|
0
|
(712)
|
(734)
|
(749)
|
(750)
|
(39)
|
|
Total Other Income |
(36)
|
(36)
|
(31)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(5)
|
(6)
|
(9)
|
(16)
|
|
Pre-Tax Income |
(440)
N/A
|
(83)
+81%
|
(449)
-443%
|
(407)
+9%
|
(745)
-83%
|
(1 429)
-92%
|
(1 547)
-8%
|
(1 884)
-22%
|
(2 707)
-44%
|
(2 795)
-3%
|
(2 959)
-6%
|
(2 973)
0%
|
(2 391)
+20%
|
|
Net Income | ||||||||||||||
Tax Provision |
(9)
|
(46)
|
(9)
|
(9)
|
6
|
50
|
14
|
16
|
4
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(448)
|
(128)
|
(458)
|
(416)
|
(739)
|
(1 380)
|
(1 532)
|
(1 867)
|
(2 703)
|
(2 796)
|
(2 960)
|
(2 975)
|
(2 392)
|
|
Net Income (Common) |
(448)
N/A
|
(128)
+71%
|
(458)
-257%
|
(416)
+9%
|
(739)
-78%
|
(1 380)
-87%
|
(1 532)
-11%
|
(1 867)
-22%
|
(2 703)
-45%
|
(2 796)
-3%
|
(2 960)
-6%
|
(2 975)
0%
|
(2 392)
+20%
|
|
EPS (Diluted) |
-17.02
N/A
|
-4.23
+75%
|
-15.94
-277%
|
-15.93
+0%
|
-25.7
-61%
|
-47.54
-85%
|
-52.66
-11%
|
-64.11
-22%
|
-92.85
-45%
|
-93.79
-1%
|
-99.51
-6%
|
-95.34
+4%
|
-77.24
+19%
|